Comprehensive Pharmacogenomics (PGx) Panel:
Note: This is a blood DNA (Gene) test.
Individuals with particular genotypes may find their metabolism capabilities for certain prescription drugs range from extremely poor to extremely fast, and may need to avoid or adjust to a higher or lower drug dosage in order to achieve a therapeutic effect. This test analyzes high-evidence markers for genes/loci of known pharmacogenomics value allowing clinicians to gain valuable insight into an individual's ability to metabolize drugs based on their genetic make-up. The pharmacogenomics panel reports genetic information only, currently we are not reporting medication information.
Test may include all or most of the following target genes: